
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Hans-Georg Eichler, M.D., M.Sc., Senior Medical Officer for the EMEA, has been named the first non-US regulatory liaison to the Clinical Trials Transformation Initiative (CTTI) Executive Committee.






